The novel biotech active delivers clinically demonstrated hyperpigmentation correction and skin brightening at a 0.45% use level, less than half the EU’s maximum concentration for kojic acid in face and hand products. SAN DIEGO, Sept. 15, 2026 /PRNewswire/ — Debut, the biotech beauty…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
